6-Chloro-2-(1-piperazinyl)quinoxaline
![]() | |
| Clinical data | |
|---|---|
| Other names | CPQ; 4-Aza-7-chloroquipazine |
| Drug class | Selective serotonin reuptake inhibitor (SSRI) |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H13ClN4 |
| Molar mass | 248.71 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
6-Chloro-2-(1-piperazinyl)quinoxaline (CPQ), also known as 4-aza-7-chloroquipazine, is a selective serotonin reuptake inhibitor (SSRI) of the arylpiperazine family related to quipazine.[1] It is highly potent and shows high selectivity for inhibiting the reuptake of serotonin over the reuptake of norepinephrine and dopamine.[1] The drug potentiates the head-twitch response (HTR) and forepaw clonus induced by 5-hydroxytryptophan (5-HTP) and antagonizes para-chloromethamphetamine (PCMA)-induced HTR and serotonergic neurotoxicity, effects which may be attributed to its serotonin reuptake inhibition.[1] The chemical synthesis of CPQ has been described.[2] CPQ was described in the scientific literature in 1978.[1]
See also
References
- 1 2 3 4 Lotti VJ, Clineschmidt BV, Haubrich D, Porter CC (September 1978). "6-Chloro-2(1-piperazinyl) quinoxaline (CPQ): action on serotonin-induced behavioral responses and interactions with chloromethamphetamine and dimethyl-meta-tyramine". Archives Internationales de Pharmacodynamie et de Therapie. 235 (1): 103–115. PMID 153735.
- ↑ Saari WS, Lumma WC (1978). "Synthesis of some 2,3- 14 C-quinoxaline derivatives". Journal of Labelled Compounds and Radiopharmaceuticals. 14 (3): 349–353. doi:10.1002/jlcr.2580140306. ISSN 0362-4803.
quinoxaline.svg.png)